Jean-Charles Schwartz, Ph.D - Publications

Affiliations: 
 

298 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Rusjan PM, Sabioni P, Di Ciano P, Mansouri E, Boileau I, Laveillé A, Capet M, Duvauchelle T, Schwartz JC, Robert P, Le Foll B. Exploring Occupancy of the Histamine H3 Receptor by Pitolisant in Humans Using Positron Emission Tomography. British Journal of Pharmacology. PMID 32293706 DOI: 10.1111/Bph.15067  0.406
2019 Lecendreux M, Plazzi G, Franco P, Jacqz-Aigrain E, Robert P, Duvauchelle T, Schwartz JC. Pharmacokinetics of pitolisant in children and adolescents with narcolepsy. Sleep Medicine. 66: 220-226. PMID 31978866 DOI: 10.1016/J.Sleep.2019.10.024  0.332
2019 Setnik B, McDonnell M, Mills C, Scart-Grès C, Robert P, Dayno JM, Schwartz JC. Evaluation of the abuse potential of pitolisant, a selective H3-receptor antagonist/inverse agonist, for the treatment of adult patients with narcolepsy with or without cataplexy. Sleep. PMID 31626696 DOI: 10.1093/Sleep/Zsz252  0.416
2019 Dauvilliers Y, Arnulf I, Szakacs Z, Leu-Semenescu S, Lecomte I, Scart-Gres C, Lecomte JM, Schwartz JC. Long-term use of pitolisant to treat patients with narcolepsy: Harmony III Study. Sleep. PMID 31529094 DOI: 10.1093/Sleep/Zsz174  0.336
2018 Thorpy M, Schwartz J, Lecomte J, Caussé C, Dayno JM. 0624 Anticataplectic Efficacy of Pitolisant, the First Potent and Highly Selective Histamine H3-Receptor Antagonist/Inverse Agonist Sleep. 41. DOI: 10.1093/Sleep/Zsy061.623  0.48
2017 Szakacs Z, Dauvilliers Y, Mikhaylov V, Poverennova I, Krylov S, Jankovic S, Sonka K, Lehert P, Lecomte I, Lecomte JM, Schwartz JC. Safety and efficacy of pitolisant on cataplexy in patients with narcolepsy: a randomised, double-blind, placebo-controlled trial. The Lancet. Neurology. PMID 28129985 DOI: 10.1016/S1474-4422(16)30333-7  0.326
2016 Levoin N, Labeeuw O, Billot X, Calmels T, Danvy D, Krief S, Berrebi-Bertrand I, Lecomte JM, Schwartz JC, Capet M. Discovery of nanomolar ligands with novel scaffolds for the histamine H4 receptor by virtual screening. European Journal of Medicinal Chemistry. 125: 565-572. PMID 27718472 DOI: 10.1016/J.Ejmech.2016.09.074  0.36
2016 Labeeuw O, Levoin N, Billot X, Danvy D, Calmels T, Krief S, Ligneau X, Berrebi-Bertrand I, Robert P, Lecomte JM, Schwartz JC, Capet M. Synthesis and evaluation of a 2-benzothiazolylphenylmethyl ether class of histamine H4 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. PMID 27692832 DOI: 10.1016/J.Bmcl.2016.09.049  0.415
2016 Schwartz JC, Lecomte JM. Clinical trials with H3-receptor inverse agonists: what they tell us about the role of histamine in the human brain. Neuropharmacology. PMID 27060410 DOI: 10.1016/J.Neuropharm.2016.04.006  0.427
2015 Capet M, Calmels T, Levoin N, Danvy D, Berrebi-Bertrand I, Stark H, Schwartz JC, Lecomte JM. Improving selectivity of dopamine D3 receptor ligands. Bioorganic & Medicinal Chemistry Letters. PMID 26723530 DOI: 10.1016/J.Bmcl.2015.12.068  0.427
2015 Ierodiakonou D, Zanobetti A, Coull BA, Melly S, Postma DS, Boezen HM, Vonk JM, Williams PV, Shapiro GG, McKone EF, Hallstrand TS, Koenig JQ, Schildcrout JS, Lumley T, Fuhlbrigge AN, ... ... Schwartz J, et al. Ambient air pollution, lung function, and airway responsiveness in asthmatic children. The Journal of Allergy and Clinical Immunology. PMID 26187234 DOI: 10.1016/J.Jaci.2015.05.028  0.348
2013 Levoin N, Labeeuw O, Krief S, Calmels T, Poupardin-Olivier O, Berrebi-Bertrand I, Lecomte JM, Schwartz JC, Capet M. Determination of the binding mode and interacting amino-acids for dibasic H3 receptor antagonists. Bioorganic & Medicinal Chemistry. 21: 4526-9. PMID 23787288 DOI: 10.1016/J.Bmc.2013.05.035  0.396
2013 Kasteleijn-Nolst Trenité D, Parain D, Genton P, Masnou P, Schwartz JC, Hirsch E. Efficacy of the histamine 3 receptor (H3R) antagonist pitolisant (formerly known as tiprolisant; BF2.649) in epilepsy: dose-dependent effects in the human photosensitivity model. Epilepsy & Behavior : E&B. 28: 66-70. PMID 23665640 DOI: 10.1016/J.Yebeh.2013.03.018  0.327
2013 Labeeuw O, Levoin N, Poupardin-Olivier O, Calmels T, Ligneau X, Berrebi-Bertrand I, Robert P, Lecomte JM, Schwartz JC, Capet M. Novel and highly potent histamine H3 receptor ligands. Part 3: an alcohol function to improve the pharmacokinetic profile. Bioorganic & Medicinal Chemistry Letters. 23: 2548-54. PMID 23535326 DOI: 10.1016/J.Bmcl.2013.02.118  0.432
2011 Levoin N, Calmels T, Krief S, Danvy D, Berrebi-Bertrand I, Lecomte JM, Schwartz JC, Capet M. Homology Model Versus X-ray Structure in Receptor-based Drug Design: A Retrospective Analysis with the Dopamine D3 Receptor. Acs Medicinal Chemistry Letters. 2: 293-7. PMID 24900310 DOI: 10.1021/Ml100288Q  0.355
2011 Levoin N, Labeeuw O, Calmels T, Poupardin-Olivier O, Berrebi-Bertrand I, Lecomte JM, Schwartz JC, Capet M. Novel and highly potent histamine H3 receptor ligands. Part 1: withdrawing of hERG activity. Bioorganic & Medicinal Chemistry Letters. 21: 5378-83. PMID 21802950 DOI: 10.1016/J.Bmcl.2011.07.006  0.457
2011 Labeeuw O, Levoin N, Poupardin-Olivier O, Calmels T, Ligneau X, Berrebi-Bertrand I, Robert P, Lecomte JM, Schwartz JC, Capet M. Novel and highly potent histamine H3 receptor ligands. Part 2: exploring the cyclohexylamine-based series. Bioorganic & Medicinal Chemistry Letters. 21: 5384-8. PMID 21783360 DOI: 10.1016/J.Bmcl.2011.06.102  0.47
2011 Schwartz JC. The histamine H3 receptor: from discovery to clinical trials with pitolisant. British Journal of Pharmacology. 163: 713-21. PMID 21615387 DOI: 10.1111/J.1476-5381.2011.01286.X  0.487
2011 Schwartz J, Garbarg M, Pollard H. Histaminergic Transmission in the Brain Comprehensive Physiology. 257-316. DOI: 10.1002/Cphy.Cp010405  0.448
2010 Walter M, Isensee K, Kottke T, Ligneau X, Camelin JC, Schwartz JC, Stark H. Azole derivatives as histamine H3 receptor antagonists, part 2: C-C and C-S coupled heterocycles. Bioorganic & Medicinal Chemistry Letters. 20: 5883-6. PMID 20727744 DOI: 10.1016/j.bmcl.2010.07.109  0.321
2010 Jean M, Renault J, Levoin N, Danvy D, Calmels T, Berrebi-Bertrand I, Robert P, Schwartz JC, Lecomte JM, Uriac P, Capet M. Synthesis and evaluation of amides surrogates of dopamine D3 receptor ligands. Bioorganic & Medicinal Chemistry Letters. 20: 5376-9. PMID 20708933 DOI: 10.1016/j.bmcl.2010.07.096  0.318
2010 Sander K, Kottke T, Hoffend C, Walter M, Weizel L, Camelin JC, Ligneau X, Schneider EH, Seifert R, Schwartz JC, Stark H. First metal-containing histamine H3 receptor ligands. Organic Letters. 12: 2578-81. PMID 20446742 DOI: 10.1021/Ol100419Y  0.402
2010 Sander K, von Coburg Y, Camelin JC, Ligneau X, Rau O, Schubert-Zsilavecz M, Schwartz JC, Stark H. Acidic elements in histamine H(3) receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 20: 1581-4. PMID 20138762 DOI: 10.1016/J.Bmcl.2010.01.089  0.418
2009 Isensee K, Amon M, Garlapati A, Galaparti A, Ligneau X, Camelin JC, Capet M, Schwartz JC, Stark H. Fluorinated non-imidazole histamine H3 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 19: 2172-5. PMID 19286376 DOI: 10.1016/j.bmcl.2009.02.110  0.303
2009 Kuder KJ, Ligneau X, Camelin JC, Lazewska D, Schwartz JC, Schunack W, Stark H, Kieć-Kononowicz K. Diether (substituted) piperidine derivatives as novel, histamine H3 receptor ligands. Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]. 58: 47-8. PMID 19266264 DOI: 10.1007/s00011-009-2002-6  0.334
2009 Isensee K, Amon M, Garlapati A, Ligneau X, Camelin JC, Capet M, Schwartz JC, Stark H. Corrigendum to "Fluorinated non-imidazole histamine H3 receptor antagonists" [Bioorg. Med. Chem. Lett. 19 (2009) 2172] (DOI:10.1016/j.bmcl.2009.02.110) Bioorganic and Medicinal Chemistry Letters. 19: 3348. DOI: 10.1016/j.bmcl.2009.02.127  0.365
2008 Łazewska D, Kuder K, Ligneau X, Schwartz JC, Schunack W, Stark H, Kieć-Kononowicz K. Piperidine variations in search for non-imidazole histamine H(3) receptor ligands. Bioorganic & Medicinal Chemistry. 16: 8729-36. PMID 18774720 DOI: 10.1016/J.Bmc.2008.07.071  0.444
2007 Saur O, Hackling AE, Perachon S, Schwartz JC, Sokoloff P, Stark H. N-(4-(4-(2-Halogenophenyl)piperazin-1-yl)butyl) substituted cinnamoyl amide derivatives as dopamine D2 and D3 receptor ligands. Archiv Der Pharmazie. 340: 178-84. PMID 17405129 DOI: 10.1002/ardp.200600196  0.32
2007 Amon M, Ligneau X, Camelin JC, Berrebi-Bertrand I, Schwartz JC, Stark H. Highly potent fluorescence-tagged nonimidazole histamine H3 receptor ligands. Chemmedchem. 2: 708-16. PMID 17361979 DOI: 10.1002/Cmdc.200600270  0.444
2007 Ligneau X, Landais L, Perrin D, Piriou J, Uguen M, Denis E, Robert P, Parmentier R, Anaclet C, Lin JS, Burban A, Arrang JM, Schwartz JC. Brain histamine and schizophrenia: potential therapeutic applications of H3-receptor inverse agonists studied with BF2.649. Biochemical Pharmacology. 73: 1215-24. PMID 17343831 DOI: 10.1016/J.Bcp.2007.01.023  0.461
2007 Ligneau X, Perrin D, Landais L, Camelin JC, Calmels TP, Berrebi-Bertrand I, Lecomte JM, Parmentier R, Anaclet C, Lin JS, Bertaina-Anglade V, la Rochelle CD, d'Aniello F, Rouleau A, Gbahou F, ... ... Schwartz JC, et al. BF2.649 [1-{3-[3-(4-Chlorophenyl)propoxy]propyl}piperidine, hydrochloride], a nonimidazole inverse agonist/antagonist at the human histamine H3 receptor: Preclinical pharmacology. The Journal of Pharmacology and Experimental Therapeutics. 320: 365-75. PMID 17005916 DOI: 10.1124/Jpet.106.111039  0.378
2006 Faucard R, Armand V, Héron A, Cochois V, Schwartz JC, Arrang JM. N-methyl-D-aspartate receptor antagonists enhance histamine neuron activity in rodent brain. Journal of Neurochemistry. 98: 1487-96. PMID 16923161 DOI: 10.1111/J.1471-4159.2006.04002.X  0.42
2006 Łazewska D, Ligneau X, Schwartz JC, Schunack W, Stark H, Kieć-Kononowicz K. Ether derivatives of 3-piperidinopropan-1-ol as non-imidazole histamine H3 receptor antagonists. Bioorganic & Medicinal Chemistry. 14: 3522-9. PMID 16466921 DOI: 10.1016/J.Bmc.2006.01.013  0.455
2006 Amon M, Ligneau X, Schwartz JC, Stark H. Fluorescent non-imidazole histamine H3 receptor ligands with nanomolar affinities. Bioorganic & Medicinal Chemistry Letters. 16: 1938-40. PMID 16434192 DOI: 10.1016/j.bmcl.2005.12.084  0.321
2005 Apelt J, Grassmann S, Ligneau X, Pertz HH, Ganellin CR, Arrang JM, Schwartz JC, Schunack W, Stark H. Search for histamine H3 receptor antagonists with combined inhibitory potency at Ntau-methyltransferase: ether derivatives. Die Pharmazie. 60: 97-106. PMID 15739896  0.37
2005 Heidler P, Zohrabi-Kalantari V, Calmels T, Capet M, Berrebi-Bertrand I, Schwartz JC, Stark H, Link A. Parallel synthesis and dopamine D3/D2 receptor screening of novel {4-[4-(2-methoxyphenyl)piperazin-1-yl]butyl}carboxamides. Bioorganic & Medicinal Chemistry. 13: 2009-14. PMID 15727854 DOI: 10.1016/J.Bmc.2005.01.018  0.467
2005 Costentin J, Marçais H, Protais P, Schwartz JC. Tolerance to hypokinesia elicited by dopamine agonists in mice: hyposensitization of autoreceptors? Life Sciences. 20: 883-6. PMID 15714774 DOI: 10.1016/0024-3205(77)90041-8  0.558
2004 Grassmann S, Apelt J, Ligneau X, Pertz HH, Arrang JM, Ganellin CR, Schwartz JC, Schunack W, Stark H. Search for histamine H(3) receptor ligands with combined inhibitory potency at histamine N-methyltransferase: omega-piperidinoalkanamine derivatives. Archiv Der Pharmazie. 337: 533-45. PMID 15476285 DOI: 10.1002/Ardp.200400897  0.433
2004 Rouleau A, Héron A, Cochois V, Pillot C, Schwartz JC, Arrang JM. Cloning and expression of the mouse histamine H3 receptor: evidence for multiple isoforms. Journal of Neurochemistry. 90: 1331-8. PMID 15341517 DOI: 10.1111/J.1471-4159.2004.02606.X  0.503
2004 Mach UR, Hackling AE, Perachon S, Ferry S, Wermuth CG, Schwartz JC, Sokoloff P, Stark H. Development of novel 1,2,3,4-tetrahydroisoquinoline derivatives and closely related compounds as potent and selective dopamine D3 receptor ligands. Chembiochem : a European Journal of Chemical Biology. 5: 508-18. PMID 15185375 DOI: 10.1002/Cbic.200300784  0.462
2004 Pelloux-Léon N, Fkyerat A, Piripitsi A, Tertiuk W, Schunack W, Stark H, Garbarg M, Ligneau X, Arrang JM, Schwartz JC, Ganellin CR. Meta-substituted aryl(thio)ethers as potent partial agonists (or antagonists) for the histamine H3 receptor lacking a nitrogen atom in the side chain. Journal of Medicinal Chemistry. 47: 3264-74. PMID 15163206 DOI: 10.1021/Jm031141P  0.333
2004 Meier G, Krause M, Hüls A, Ligneau X, Pertz HH, Arrang JM, Ganellin CR, Schwartz JC, Schunack W, Stark H. 4-(omega-(alkyloxy)alkyl)-1H-imidazole derivatives as histamine H(3) receptor antagonists/agonists. Journal of Medicinal Chemistry. 47: 2678-87. PMID 15115409 DOI: 10.1021/Jm031065Q  0.463
2004 Mikó T, Ligneau X, Pertz HH, Arrang JM, Ganellin CR, Schwartz JC, Schunack W, Stark H. Structural variations of 1-(4-(phenoxymethyl)benzyl)piperidines as nonimidazole histamine H3 receptor antagonists. Bioorganic & Medicinal Chemistry. 12: 2727-36. PMID 15110854 DOI: 10.1016/J.Bmc.2004.03.009  0.451
2004 Guillin O, Griffon N, Diaz J, Le Foll B, Bezard E, Gross C, Lammers C, Stark H, Carroll P, Schwartz JC, Sokoloff P. Brain-derived neurotrophic factor and the plasticity of the mesolimbic dopamine pathway. International Review of Neurobiology. 59: 425-44. PMID 15006497 DOI: 10.1016/S0074-7742(04)59016-5  0.308
2003 Gbahou F, Rouleau A, Morisset S, Parmentier R, Crochet S, Lin JS, Ligneau X, Tardivel-Lacombe J, Stark H, Schunack W, Ganellin CR, Schwartz JC, Arrang JM. Protean agonism at histamine H3 receptors in vitro and in vivo. Proceedings of the National Academy of Sciences of the United States of America. 100: 11086-91. PMID 12960366 DOI: 10.1073/Pnas.1932276100  0.451
2003 Hackling A, Ghosh R, Perachon S, Mann A, Höltje HD, Wermuth CG, Schwartz JC, Sippl W, Sokoloff P, Stark H. N-(omega-(4-(2-methoxyphenyl)piperazin-1-yl)alkyl)carboxamides as dopamine D2 and D3 receptor ligands. Journal of Medicinal Chemistry. 46: 3883-99. PMID 12930150 DOI: 10.1021/Jm030836N  0.435
2003 Leriche L, Schwartz JC, Sokoloff P. The dopamine D3 receptor mediates locomotor hyperactivity induced by NMDA receptor blockade. Neuropharmacology. 45: 174-81. PMID 12842123 DOI: 10.1016/S0028-3908(03)00145-X  0.461
2003 Schwartz JC, Morisset S, Rouleau A, Ligneau X, Gbahou F, Tardivel-Lacombe J, Stark H, Schunack W, Ganellin CR, Arrang JM. Therapeutic implications of constitutive activity of receptors: the example of the histamine H3 receptor. Journal of Neural Transmission. Supplementum. 1-16. PMID 12830926  0.395
2003 Grassmann S, Apelt J, Sippl W, Ligneau X, Pertz HH, Zhao YH, Arrang JM, Ganellin CR, Schwartz JC, Schunack W, Stark H. Imidazole derivatives as a novel class of hybrid compounds with inhibitory histamine N-methyltransferase potencies and histamine hH3 receptor affinities. Bioorganic & Medicinal Chemistry. 11: 2163-74. PMID 12713826 DOI: 10.1016/S0968-0896(03)00120-2  0.474
2003 Mikó T, Ligneau X, Pertz HH, Ganellin CR, Arrang JM, Schwartz JC, Schunack W, Stark H. Novel nonimidazole histamine H3 receptor antagonists: 1-(4-(phenoxymethyl)benzyl)piperidines and related compounds. Journal of Medicinal Chemistry. 46: 1523-30. PMID 12672253 DOI: 10.1021/Jm021084K  0.483
2003 Pillot C, Héron A, Schwartz JC, Arrang JM. Ciproxifan, a histamine H3-receptor antagonist/inverse agonist, modulates the effects of methamphetamine on neuropeptide mRNA expression in rat striatum. The European Journal of Neuroscience. 17: 307-14. PMID 12542667 DOI: 10.1046/J.1460-9568.2003.02422.X  0.453
2002 Pillot C, Heron A, Cochois V, Tardivel-Lacombe J, Ligneau X, Schwartz JC, Arrang JM. A detailed mapping of the histamine H(3) receptor and its gene transcripts in rat brain. Neuroscience. 114: 173-93. PMID 12207964 DOI: 10.1016/S0306-4522(02)00135-5  0.371
2002 Sasse A, Ligneau X, Rouleau A, Elz S, Ganellin CR, Arrang JM, Schwartz JC, Schunack W, Stark H. Influence of bulky substituents on histamine h(3) receptor agonist/antagonist properties. Journal of Medicinal Chemistry. 45: 4000-10. PMID 12190321 DOI: 10.1021/Jm020910M  0.459
2002 Pillot C, Ortiz J, Héron A, Ridray S, Schwartz JC, Arrang JM. Ciproxifan, a histamine H3-receptor antagonist/inverse agonist, potentiates neurochemical and behavioral effects of haloperidol in the rat. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 7272-80. PMID 12177222 DOI: 10.1523/Jneurosci.22-16-07272.2002  0.502
2002 Le Foll B, Francès H, Diaz J, Schwartz JC, Sokoloff P. Role of the dopamine D3 receptor in reactivity to cocaine-associated cues in mice. The European Journal of Neuroscience. 15: 2016-26. PMID 12099907 DOI: 10.1046/J.1460-9568.2002.02049.X  0.302
2002 Meier G, Ligneau X, Pertz HH, Ganellin CR, Schwartz JC, Schunack W, Stark H. Piperidino-hydrocarbon compounds as novel non-imidazole histamine H(3)-receptor antagonists. Bioorganic & Medicinal Chemistry. 10: 2535-42. PMID 12057642 DOI: 10.1016/S0968-0896(02)00115-3  0.4
2002 Trottier S, Chotard C, Traiffort E, Unmehopa U, Fisser B, Swaab DF, Schwartz JC. Co-localization of histamine with GABA but not with galanin in the human tuberomamillary nucleus. Brain Research. 939: 52-64. PMID 12020851 DOI: 10.1016/S0006-8993(02)02546-5  0.58
2002 Wiecek M, Kieć-Kononowicz K, Sasse A, Ligneau X, Schwartz JC, Schunack W, Stark H. Impact of lipophilicity on the pharmacological properties of histamine H3-receptor antagonists of the cycloalkyl carbamate class. Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]. 51: S71-2. PMID 12013417 DOI: 10.1007/PL00000274  0.351
2002 Grassmann S, Sadek B, Ligneau X, Elz S, Ganellin CR, Arrang JM, Schwartz JC, Stark H, Schunack W. Progress in the proxifan class: heterocyclic congeners as novel potent and selective histamine H(3)-receptor antagonists. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 15: 367-78. PMID 11988398 DOI: 10.1016/S0928-0987(02)00024-6  0.504
2002 Chotard C, Ouimet T, Morisset S, Sahm U, Schwartz JC, Trottier S. Effects of histamine H3 receptor agonist and antagonist on histamine co-transmitter expression in rat brain. Journal of Neural Transmission (Vienna, Austria : 1996). 109: 293-306. PMID 11956952 DOI: 10.1007/s007020200024  0.345
2002 Apelt J, Ligneau X, Pertz HH, Arrang JM, Ganellin CR, Schwartz JC, Schunack W, Stark H. Development of a new class of nonimidazole histamine H(3) receptor ligands with combined inhibitory histamine N-methyltransferase activity. Journal of Medicinal Chemistry. 45: 1128-41. PMID 11855993 DOI: 10.1021/Jm0110845  0.471
2002 Rouleau A, Ligneau X, Tardivel-Lacombe J, Morisset S, Gbahou F, Schwartz JC, Arrang JM. Histamine H3-receptor-mediated [35S]GTP gamma[S] binding: evidence for constitutive activity of the recombinant and native rat and human H3 receptors. British Journal of Pharmacology. 135: 383-92. PMID 11815373 DOI: 10.1038/sj.bjp.0704490  0.347
2002 Morisset S, Pilon C, Tardivel-Lacombe J, Weinstein D, Rostene W, Betancur C, Sokoloff P, Schwartz JC, Arrang JM. Acute and chronic effects of methamphetamine on tele-methylhistamine levels in mouse brain: selective involvement of the D(2) and not D(3) receptor. The Journal of Pharmacology and Experimental Therapeutics. 300: 621-8. PMID 11805225 DOI: 10.1124/jpet.300.2.621  0.337
2001 Sokoloff P, Le Foll B, Perachon S, Bordet R, Ridray S, Schwartz JC. The dopamine D3 receptor and drug addiction. Neurotoxicity Research. 3: 433-41. PMID 14715457 DOI: 10.1007/Bf03033202  0.345
2001 Stark H, Arrang JM, Ligneau X, Garbarg M, Ganellin CR, Schwartz JC, Schunack W. The histamine H3 receptor and its ligands. Progress in Medicinal Chemistry. 38: 279-308. PMID 11774797 DOI: 10.1016/S0079-6468(08)70096-1  0.477
2001 Schwartz JC, Morisset S, Rouleau A, Tardivel-Lacombe J, Gbahou F, Ligneau X, Héron A, Sasse A, Stark H, Schunack W, Ganellin RC, Arrang JM. Application of genomics to drug design: the example of the histamine H3 receptor. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 11: 441-8. PMID 11704421 DOI: 10.1016/S0924-977X(01)00121-3  0.476
2001 Héron A, Rouleau A, Cochois V, Pillot C, Schwartz JC, Arrang JM. Expression analysis of the histamine H(3) receptor in developing rat tissues. Mechanisms of Development. 105: 167-73. PMID 11429293 DOI: 10.1016/S0925-4773(01)00389-6  0.347
2001 Meier G, Apelt J, Reichert U, Grassmann S, Ligneau X, Elz S, Leurquin F, Ganellin CR, Schwartz JC, Schunack W, Stark H. Influence of imidazole replacement in different structural classes of histamine H(3)-receptor antagonists. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 13: 249-59. PMID 11384847 DOI: 10.1016/S0928-0987(01)00106-3  0.4
2001 Guillin O, Diaz J, Carroll P, Griffon N, Schwartz JC, Sokoloff P. BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization. Nature. 411: 86-9. PMID 11333982 DOI: 10.1038/35075076  0.383
2001 Stark H, Sippl W, Ligneau X, Arrang JM, Ganellin CR, Schwartz JC, Schunack W. Different antagonist binding properties of human and rat histamine H3 receptors. Bioorganic & Medicinal Chemistry Letters. 11: 951-4. PMID 11294398 DOI: 10.1016/S0960-894X(01)00090-7  0.489
2001 Sasse A, Ligneau X, Sadek B, Elz S, Pertz HH, Ganellin CR, Arrang JM, Schwartz JC, Schunack W, Stark H. Benzophenone derivatives and related compounds as potent histamine H3-receptor antagonists and potential PET/SPECT ligands. Archiv Der Pharmazie. 334: 45-52. PMID 11268774 DOI: 10.1002/1521-4184(200102)334:2<45::AID-ARDP45>3.0.CO;2-2  0.349
2001 Tardivel-Lacombe J, Morisset S, Gbahou F, Schwartz JC, Arrang JM. Chromosomal mapping and organization of the human histamine H3 receptor gene. Neuroreport. 12: 321-4. PMID 11209943 DOI: 10.1097/00001756-200102120-00028  0.33
2001 Stark H, Krause M, Rouleau A, Garbarg M, Schwartz JC, Schunack W. Enzyme-catalyzed prodrug approaches for the histamine H3-receptor agonist (R)-alpha-methylhistamine. Bioorganic & Medicinal Chemistry. 9: 191-8. PMID 11197341 DOI: 10.1016/S0968-0896(00)00237-6  0.369
2001 Morisset S, Sasse A, Gbahou F, Héron A, Ligneau X, Tardivel-Lacombe J, Schwartz JC, Arrang JM. The rat H3 receptor: gene organization and multiple isoforms. Biochemical and Biophysical Research Communications. 280: 75-80. PMID 11162480 DOI: 10.1006/Bbrc.2000.4073  0.411
2000 Kieć-Kononowicz K, Wiecek M, Sasse A, Ligneau X, Elz S, Ganellin CR, Schwartz JC, Stark H, Schunack W. Importance of the lipophilic group in carbamates having histamine H3-receptor antagonist activity. Die Pharmazie. 55: 349-55. PMID 11828613  0.38
2000 Morisset S, Rouleau A, Ligneau X, Gbahou F, Tardivel-Lacombe J, Stark H, Schunack W, Ganellin CR, Schwartz JC, Arrang JM. High constitutive activity of native H3 receptors regulates histamine neurons in brain. Nature. 408: 860-4. PMID 11130725 DOI: 10.1038/35048583  0.376
2000 Diaz J, Pilon C, Le Foll B, Gros C, Triller A, Schwartz JC, Sokoloff P. Dopamine D3 receptors expressed by all mesencephalic dopamine neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 8677-84. PMID 11102473 DOI: 10.1523/Jneurosci.20-23-08677.2000  0.376
2000 Stark H, Ligneau X, Sadek B, Ganellin CR, Arrang JM, Schwartz JC, Schunack W. Analogues and derivatives of ciproxifan, a novel prototype for generating potent histamine H3-receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 10: 2379-82. PMID 11055360 DOI: 10.1016/S0960-894X(00)00473-X  0.48
2000 Stark H, Sadek B, Krause M, Hüls A, Ligneau X, Ganellin CR, Arrang JM, Schwartz JC, Schunack W. Novel histamine H(3)-receptor antagonists with carbonyl-substituted 4-(3-(phenoxy)propyl)-1H-imidazole structures like ciproxifan and related compounds. Journal of Medicinal Chemistry. 43: 3987-94. PMID 11052804 DOI: 10.1021/jm000966l  0.361
2000 Sasse A, Sadek B, Ligneau X, Elz S, Pertz HH, Luger P, Ganellin CR, Arrang JM, Schwartz JC, Schunack W, Stark H. New histamine H(3)-receptor ligands of the proxifan series: imoproxifan and other selective antagonists with high oral in vivo potency. Journal of Medicinal Chemistry. 43: 3335-43. PMID 10966752 DOI: 10.1021/Jm000971P  0.376
2000 Lammers CH, Diaz J, Schwartz JC, Sokoloff P. Selective increase of dopamine D3 receptor gene expression as a common effect of chronic antidepressant treatments. Molecular Psychiatry. 5: 378-88. PMID 10889548  0.314
2000 Bordet R, Ridray S, Schwartz JC, Sokoloff P. Involvement of the direct striatonigral pathway in levodopa-induced sensitization in 6-hydroxydopamine-lesioned rats. The European Journal of Neuroscience. 12: 2117-23. PMID 10886351 DOI: 10.1046/J.1460-9568.2000.00089.X  0.475
2000 Sasse A, Stark H, Ligneau X, Elz S, Reidemeister S, Ganellin CR, Schwartz JC, Schunack W. (Partial) agonist/antagonist properties of novel diarylalkyl carbamates on histamine H3 receptors. Bioorganic & Medicinal Chemistry. 8: 1139-49. PMID 10882024 DOI: 10.1016/S0968-0896(00)00050-X  0.463
2000 Ouimet T, Facchinetti P, Rose C, Bonhomme MC, Gros C, Schwartz JC, Tanja O. Neprilysin II: A putative novel metalloprotease and its isoforms in CNS and testis. Biochemical and Biophysical Research Communications. 271: 565-70. PMID 10814502 DOI: 10.1006/Bbrc.2000.2664  0.333
2000 Tardivel-Lacombe J, Rouleau A, Héron A, Morisset S, Pillot C, Cochois V, Schwartz JC, Arrang JM. Cloning and cerebral expression of the guinea pig histamine H3 receptor: evidence for two isoforms. Neuroreport. 11: 755-9. PMID 10757514 DOI: 10.1097/00001756-200003200-00020  0.47
2000 Reidemeister S, Stark H, Ligneau X, Ganellin CR, Schwartz JC, Schunack W. Substituted N-phenylcarbamates as histamine H3 receptor antagonists with improved in vivo potency. Die Pharmazie. 55: 83-6. PMID 10723763  0.392
2000 Schwartz JC, Diaz J, Pilon C, Sokoloff P. Possible implications of the dopamine D(3) receptor in schizophrenia and in antipsychotic drug actions. Brain Research. Brain Research Reviews. 31: 277-87. PMID 10719154 DOI: 10.1016/S0165-0173(99)00043-0  0.438
2000 Perachon S, Betancur C, Pilon C, Rostène W, Schwartz JC, Sokoloff P. Role of dopamine D3 receptors in thermoregulation: a reappraisal. Neuroreport. 11: 221-5. PMID 10683862 DOI: 10.1097/00001756-200001170-00044  0.449
2000 Morisset S, Traiffort E, Arrang JM, Schwartz JC. Changes in histamine H3 receptor responsiveness in mouse brain. Journal of Neurochemistry. 74: 339-46. PMID 10617138 DOI: 10.1046/J.1471-4159.2000.0740339.X  0.685
1999 Sasse A, Stark H, Reidemeister S, Hüls A, Elz S, Ligneau X, Ganellin CR, Schwartz JC, Schunack W. Novel partial agonists for the histamine H(3) receptor with high in vitro and in vivo activity. Journal of Medicinal Chemistry. 42: 4269-74. PMID 10514298 DOI: 10.1021/Jm991068W  0.409
1999 Pilla M, Perachon S, Sautel F, Garrido F, Mann A, Wermuth CG, Schwartz JC, Everitt BJ, Sokoloff P. Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist. Nature. 400: 371-5. PMID 10432116 DOI: 10.1038/22560  0.369
1999 Allard J, Barron S, Trottier S, Cervera P, Daumas-Duport C, Leguern E, Brice A, Schwartz JC, Sokoloff P. Edg-2 in myelin-forming cells: isoforms, genomic mapping, and exclusion in Charcot-Marie-Tooth disease. Glia. 26: 176-85. PMID 10384882 DOI: 10.1002/(Sici)1098-1136(199904)26:2<176::Aid-Glia8>3.0.Co;2-K  0.34
1999 Drutel G, Héron A, Kathmann M, Gros C, Macé S, Plotkine M, Schwartz JC, Arrang JM. ARNT2, a transcription factor for brain neuron survival? The European Journal of Neuroscience. 11: 1545-53. PMID 10215907 DOI: 10.1046/J.1460-9568.1999.00562.X  0.303
1999 Perachon S, Schwartz JC, Sokoloff P. Functional potencies of new antiparkinsonian drugs at recombinant human dopamine D1, D2 and D3 receptors. European Journal of Pharmacology. 366: 293-300. PMID 10082211  0.313
1999 Sasse A, Kiec-Kononowicz K, Stark H, Motyl M, Reidemeister S, Ganellin CR, Ligneau X, Schwartz JC, Schunack W. Development of chiral N-alkylcarbamates as new leads for potent and selective H3-receptor antagonists: synthesis, capillary electrophoresis, and in vitro and oral in vivo activity. Journal of Medicinal Chemistry. 42: 593-600. PMID 10052966 DOI: 10.1021/jm9804376  0.392
1999 Morisset S, Sahm UG, Traiffort E, Tardivel-Lacombe J, Arrang JM, Schwartz JC. Atypical neuroleptics enhance histamine turnover in brain via 5-Hydroxytryptamine2A receptor blockade. The Journal of Pharmacology and Experimental Therapeutics. 288: 590-6. PMID 9918563  0.709
1999 Matzanke N, Löwe W, Perachon S, Sokoloff P, Schwartz J, Stark H. Heterocyclic congeners of PD 128,907 with a partially hydrogenated benzomorpholine moiety as potential dopamine D3-receptor ligands European Journal of Medicinal Chemistry. 34: 791-798. DOI: 10.1016/S0223-5234(99)00213-5  0.427
1998 Sokoloff P, Diaz J, Bordet R, Griffon N, Perachon S, Pilon C, Ridray S, Schwartz JC. [Function and therapeutic potential of the dopamine D3 receptor]. Comptes Rendus Des Sã©Ances De La Sociã©Tã© De Biologie Et De Ses Filiales. 192: 1111-25. PMID 10101607  0.358
1998 Ganellin CR, Leurquin F, Piripitsi A, Arrang JM, Garbarg M, Ligneau X, Schunack W, Schwartz JC. Synthesis of potent non-imidazole histamine H3-receptor antagonists. Archiv Der Pharmazie. 331: 395-404. PMID 9923195 DOI: 10.1002/(SICI)1521-4184(199812)331:12<395::AID-ARDP395>3.0.CO;2-7  0.317
1998 Stark H, Ligneau X, Arrang JM, Schwartz JC, Schunack W. General construction pattern of histamine H3-receptor antagonists: change of a paradigm. Bioorganic & Medicinal Chemistry Letters. 8: 2011-6. PMID 9873477  0.376
1998 Krause M, Ligneau X, Stark H, Garbarg M, Schwartz JC, Schunack W. 4-Alkynylphenyl imidazolylpropyl ethers as selective histamine H3-receptor antagonists with high oral central nervous system activity. Journal of Medicinal Chemistry. 41: 4171-6. PMID 9767653 DOI: 10.1021/Jm9802970  0.484
1998 Ridray S, Griffon N, Mignon V, Souil E, Carboni S, Diaz J, Schwartz JC, Sokoloff P. Coexpression of dopamine D1 and D3 receptors in islands of Calleja and shell of nucleus accumbens of the rat: opposite and synergistic functional interactions. The European Journal of Neuroscience. 10: 1676-86. PMID 9751140 DOI: 10.1046/J.1460-9568.1998.00173.X  0.409
1998 Stark H, Hüls A, Ligneau X, Purand K, Pertz H, Arrang JM, Schwartz JC, Schunack W. Development of FUB 181, a selective histamine H3-receptor antagonist of high oral in vivo potency with 4-(omega-(arylalkyloxy)alkyl)-1H-imidazole structure. Archiv Der Pharmazie. 331: 211-8. PMID 9713254 DOI: 10.1002/(Sici)1521-4184(199806)331:6<211::Aid-Ardp211>3.0.Co;2-P  0.459
1998 Schwartz JC, Diaz J, Bordet R, Griffon N, Perachon S, Pilon C, Ridray S, Sokoloff P. Functional implications of multiple dopamine receptor subtypes: the D1/D3 receptor coexistence. Brain Research. Brain Research Reviews. 26: 236-42. PMID 9651537 DOI: 10.1016/S0165-0173(97)00046-5  0.452
1998 Suzuki M, Hurd YL, Sokoloff P, Schwartz JC, Sedvall G. D3 dopamine receptor mRNA is widely expressed in the human brain. Brain Research. 779: 58-74. PMID 9473588 DOI: 10.1016/S0006-8993(97)01078-0  0.416
1998 Bruins-Slot L, Gorwood P, Bouvard M, Blot P, Adès J, Feingold J, Schwartz JC, Mouren-Siméoni MC. Lack of association between anorexia nervosa and D3 dopamine receptor gene. Biological Psychiatry. 43: 76-8. PMID 9442347 DOI: 10.1016/S0006-3223(97)00199-6  0.358
1997 Hill SJ, Ganellin CR, Timmerman H, Schwartz JC, Shankley NP, Young JM, Schunack W, Levi R, Haas HL. International Union of Pharmacology. XIII. Classification of histamine receptors. Pharmacological Reviews. 49: 253-78. PMID 9311023  0.301
1997 Vizuete ML, Traiffort E, Bouthenet ML, Ruat M, Souil E, Tardivel-Lacombe J, Schwartz JC. Detailed mapping of the histamine H2 receptor and its gene transcripts in guinea-pig brain. Neuroscience. 80: 321-43. PMID 9284338 DOI: 10.1016/S0306-4522(97)00010-9  0.688
1997 Stark H, Hüls A, Ligneau X, Arrang JM, Schwartz JC, Schunack W. Search for novel leads for histamine H3-receptor antagonists: oxygen-containing derivatives. Die Pharmazie. 52: 495-500. PMID 9266588  0.403
1997 Stark H, Ligneau X, Lipp R, Arrang JM, Schwartz JC, Schunack W. Search for novel leads for histamine H3-receptor antagonists: amine derivatives. Die Pharmazie. 52: 419-23. PMID 9260265  0.392
1997 Diaz J, Ridray S, Mignon V, Griffon N, Schwartz JC, Sokoloff P. Selective expression of dopamine D3 receptor mRNA in proliferative zones during embryonic development of the rat brain. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 17: 4282-92. PMID 9151745 DOI: 10.1523/Jneurosci.17-11-04282.1997  0.368
1997 Bordet R, Ridray S, Carboni S, Diaz J, Sokoloff P, Schwartz JC. Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa. Proceedings of the National Academy of Sciences of the United States of America. 94: 3363-7. PMID 9096399 DOI: 10.1073/Pnas.94.7.3363  0.474
1997 Griffon N, Pilon C, Sautel F, Schwartz JC, Sokoloff P. Two intracellular signaling pathways for the dopamine D3 receptor: opposite and synergistic interactions with cyclic AMP. Journal of Neurochemistry. 68: 1-9. PMID 8978703 DOI: 10.1046/J.1471-4159.1997.68010001.X  0.48
1996 Griffon N, Pilon C, Sautel F, Schwartz JC, Sokoloff P. Antipsychotics with inverse agonist activity at the dopamine D3 receptor. Journal of Neural Transmission (Vienna, Austria : 1996). 103: 1163-75. PMID 9013403  0.385
1996 Morisset S, Traiffort E, Schwartz JC. Inhibition of histamine versus acetylcholine metabolism as a mechanism of tacrine activity. European Journal of Pharmacology. 315: R1-2. PMID 8960873 DOI: 10.1016/S0014-2999(96)00738-8  0.697
1996 Hüls A, Purand K, Stark H, Reidemeister S, Ligneau X, Arrang JM, Schwartz JC, Schunack W. Novel histamine H3-receptor antagonists with benzyl ether structure or related moieties: synthesis and structure-activity relationships. Archiv Der Pharmazie. 329: 379-85. PMID 8915097 DOI: 10.1002/Ardp.19963290802  0.488
1996 Héron A, Traiffort E, Allix M, Dimitriadou V, Schwartz JC. Prodynorphin mRNA expression in the rat dentate gyrus after cerebral ischemia. Neuropeptides. 30: 355-8. PMID 8914861 DOI: 10.1016/S0143-4179(96)90024-4  0.632
1996 Soldani G, Garbarg M, Intorre L, Bertini S, Rouleau A, Schwartz JC. Modulation of pentagastrin-induced histamine release by histamine H3 receptors in the dog. Scandinavian Journal of Gastroenterology. 31: 631-8. PMID 8819209  0.302
1996 Drutel G, Kathmann M, Heron A, Schwartz JC, Arrang JM. Cloning and selective expression in brain and kidney of ARNT2 homologous to the Ah receptor nuclear translocator (ARNT). Biochemical and Biophysical Research Communications. 225: 333-9. PMID 8753765 DOI: 10.1006/Bbrc.1996.1176  0.385
1996 Stark H, Purand K, Ligneau X, Rouleau A, Arrang JM, Garbarg M, Schwartz JC, Schunack W. Novel carbamates as potent histamine H3 receptor antagonists with high in vitro and oral in vivo activity. Journal of Medicinal Chemistry. 39: 1157-63. PMID 8676353 DOI: 10.1021/Jm9507688  0.496
1996 Griffon N, Sautel F, Pilon C, Lévesque D, Sokoloff P, Schwartz JC, Diaz J, Simon P, Costentin J, Mann A, Wermuth CG. Functional models for the dopamine D3 receptor. Biochemical Society Transactions. 24: 193-8. PMID 8674660 DOI: 10.1042/bst0240193  0.54
1996 Krause M, Rouleau A, Stark H, Luger P, Garbarg M, Schwartz JC, Schunack W. New potent azomethine prodrugs of the histamine H3-receptor agonist (R)-alpha-methylhistamine containing a heteroarylphenyl partial structure. Archiv Der Pharmazie. 329: 209-15. PMID 8669985 DOI: 10.1002/Ardp.19963290407  0.45
1996 Stark H, Purand K, Hüls A, Ligneau X, Garbarg M, Schwartz JC, Schunack W. [125I]iodoproxyfan and related compounds: a reversible radioligand and novel classes of antagonists with high affinity and selectivity for the histamine H3 receptor. Journal of Medicinal Chemistry. 39: 1220-6. PMID 8632428 DOI: 10.1021/Jm9504767  0.476
1995 Schwartz JC, Griffon N, Diaz J, Levesque D, Sautel F, Sokoloff P, Simon P, Costentin J, Garrido F, Mann A. The D3 receptor and its relevance in psychiatry. International Clinical Psychopharmacology. 10: 15-20. PMID 8866761  0.335
1995 Griffon N, Sokoloff P, Diaz J, Lévesque D, Sautel F, Schwartz JC, Simon P, Costentin J, Garrido F, Mann A. The dopamine D3 receptor and schizophrenia: pharmacological, anatomical and genetic approaches. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 5: 3-9. PMID 8775753 DOI: 10.1016/0924-977X(95)00030-S  0.595
1995 Normant E, Martres MP, Schwartz JC, Gros C. Purification, cDNA cloning, functional expression, and characterization of a 26-kDa endogenous mammalian carboxypeptidase inhibitor. Proceedings of the National Academy of Sciences of the United States of America. 92: 12225-9. PMID 8618874 DOI: 10.1073/Pnas.92.26.12225  0.329
1995 Sautel F, Griffon N, Sokoloff P, Schwartz JC, Launay C, Simon P, Costentin J, Schoenfelder A, Garrido F, Mann A. Nafadotride, a potent preferential dopamine D3 receptor antagonist, activates locomotion in rodents. The Journal of Pharmacology and Experimental Therapeutics. 275: 1239-46. PMID 8531087  0.365
1995 Lévesque D, Martres MP, Diaz J, Griffon N, Lammers CH, Sokoloff P, Schwartz JC. A paradoxical regulation of the dopamine D3 receptor expression suggests the involvement of an anterograde factor from dopamine neurons. Proceedings of the National Academy of Sciences of the United States of America. 92: 1719-23. PMID 7878047 DOI: 10.1073/Pnas.92.5.1719  0.475
1995 Traiffort E, Vizuete ML, Tardivel-Lacombe J, Souil E, Schwartz JC, Ruat M. The guinea pig histamine H2 receptor: gene cloning, tissue expression and chromosomal localization of its human counterpart. Biochemical and Biophysical Research Communications. 211: 570-7. PMID 7794271 DOI: 10.1006/Bbrc.1995.1851  0.691
1995 Sautel F, Griffon N, Lévesque D, Pilon C, Schwartz JC, Sokoloff P. A functional test identifies dopamine agonists selective for D3 versus D2 receptors. Neuroreport. 6: 329-32. PMID 7756621 DOI: 10.1097/00001756-199501000-00026  0.441
1995 Ganellin CR, Fkyerat A, Hosseini SK, Khalaf YS, Piripitsi A, Tertiuk W, Arrang JM, Garbarg M, Ligneau X, Schwartz JC. Structure-activity studies with histamine H3-receptor ligands. Journal De Pharmacie De Belgique. 50: 179-87. PMID 7674117  0.371
1995 Normant E, Gros C, Schwartz JC. Carboxypeptidase A isoforms produced by distinct genes or alternative splicing in brain and other extrapancreatic tissues. The Journal of Biological Chemistry. 270: 20543-9. PMID 7657630 DOI: 10.1074/Jbc.270.35.20543  0.314
1995 Vizuete ML, Dimitriadou V, Traiffort E, Griffon N, Heron A, Schwartz JC. Endogenous histamine induces c-fos expression within paraventricular and supraoptic nuclei. Neuroreport. 6: 1041-4. PMID 7632891 DOI: 10.1097/00001756-199505090-00023  0.699
1995 Kieć-Kononowicz K, Ligneau X, Schwartz JC, Schunack W. Pyrazoles as potential histamine H3-receptor antagonists. Archiv Der Pharmazie. 328: 469-72. PMID 7611843 DOI: 10.1002/Ardp.19953280513  0.507
1995 Kieć-Kononowicz K, Ligneau X, Stark H, Schwartz JC, Schunack W. Azines and diazines as potential histamine H3-receptor antagonists. Archiv Der Pharmazie. 328: 445-50. PMID 7611840 DOI: 10.1002/Ardp.19953280509  0.505
1995 Arrang JM, Drutel G, Garbarg M, Ruat M, Traiffort E, Schwartz JC. Molecular and functional diversity of histamine receptor subtypes. Annals of the New York Academy of Sciences. 757: 314-23. PMID 7611688 DOI: 10.1111/J.1749-6632.1995.Tb17489.X  0.672
1995 Sokoloff P, Diaz J, Levesque D, Pilon C, Dimitriadou V, Griffon N, Lammers CH, Martres MP, Schwartz JC. Novel dopamine receptor subtypes as targets for antipsychotic drugs. Annals of the New York Academy of Sciences. 757: 278-92. PMID 7611685 DOI: 10.1111/J.1749-6632.1995.Tb17486.X  0.388
1995 Diaz J, Lévesque D, Lammers CH, Griffon N, Martres MP, Schwartz JC, Sokoloff P. Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain. Neuroscience. 65: 731-45. PMID 7609872  0.351
1995 Arrang JM, Drutel G, Schwartz JC. Characterization of histamine H3 receptors regulating acetylcholine release in rat entorhinal cortex. British Journal of Pharmacology. 114: 1518-22. PMID 7606356  0.392
1995 Göthert M, Garbarg M, Hey JA, Schlicker E, Schwartz JC, Levi R. New aspects of the role of histamine in cardiovascular function: identification, characterization, and potential pathophysiological importance of H3 receptors. Canadian Journal of Physiology and Pharmacology. 73: 558-64. PMID 7585321 DOI: 10.1139/y95-071  0.369
1995 Griffon N, Pilon C, Schwartz JC, Sokoloff P. The preferential dopamine D3 receptor ligand, (+)-UH232, is a partial agonist. European Journal of Pharmacology. 282: R3-4. PMID 7498261 DOI: 10.1016/0014-2999(95)00460-3  0.483
1995 Sokoloff P, Schwartz JC. Novel dopamine receptors half a decade later. Trends in Pharmacological Sciences. 16: 270-5. PMID 7482988 DOI: 10.1016/S0165-6147(00)89044-6  0.469
1995 Mei YA, Griffon N, Buquet C, Martres MP, Vaudry H, Schwartz JC, Sokoloff P, Cazin L. Activation of dopamine D4 receptor inhibits an L-type calcium current in cerebellar granule cells. Neuroscience. 68: 107-16. PMID 7477916  0.302
1995 Schwartz JC, Griffon N, Diaz J, Levesque D, Sautel F, Sokoloff P, Simon P, Costentin J, Garrido F, Mann A, Wermuth C. The D3 receptor and its relevance in psychiatry International Clinical Psychopharmacology. 10: 15-20. DOI: 10.1097/00004850-199509000-00003  0.545
1995 Schwartz J, Sokoloff P. Schwartz and Sokoloff reply: Selective agonists and antagonists are needed to determine a functional role for dopamine D3 receptors Trends in Pharmacological Sciences. 16: 407-408. DOI: 10.1016/S0165-6147(00)89089-6  0.445
1995 Stark H, Lipp R, Arrang JM, Garbarg M, Ligneau X, Schwartz JC, Schunack W. New potent histamine H3-receptor antagonists of the amide type European Journal of Pharmaceutical Sciences. 3: 95-104. DOI: 10.1016/0928-0987(94)00079-F  0.466
1995 Lipp R, Stark H, Arrang JM, Garbarg M, Schwartz JC, Schunack W. Synthesis and histamine H3-receptor agonist activity of mono- and dialkyl-substituted histamine derivatives European Journal of Medicinal Chemistry. 30: 219-225. DOI: 10.1016/0223-5234(96)88228-6  0.456
1994 Leurs R, Traiffort E, Arrang JM, Tardivel-Lacombe J, Ruat M, Schwartz JC. Guinea pig histamine H1 receptor. II. Stable expression in Chinese hamster ovary cells reveals the interaction with three major signal transduction pathways. Journal of Neurochemistry. 62: 519-27. PMID 8294914 DOI: 10.1046/J.1471-4159.1994.62020519.X  0.633
1994 Traiffort E, Leurs R, Arrang JM, Tardivel-Lacombe J, Diaz J, Schwartz JC, Ruat M. Guinea pig histamine H1 receptor. I. Gene cloning, characterization, and tissue expression revealed by in situ hybridization. Journal of Neurochemistry. 62: 507-18. PMID 8294913 DOI: 10.1046/J.1471-4159.1994.62020507.X  0.693
1994 Griffon N, Mignon V, Facchinetti P, Diaz J, Schwartz JC, Sokoloff P. Molecular cloning and characterization of the rat fifth melanocortin receptor. Biochemical and Biophysical Research Communications. 200: 1007-14. PMID 8179577  0.314
1994 Diaz J, Vizuete ML, Traiffort E, Arrang JM, Ruat M, Schwartz JC. Localization of the histamine H2 receptor and gene transcripts in rat stomach: back to parietal cells. Biochemical and Biophysical Research Communications. 198: 1195-202. PMID 8117277 DOI: 10.1006/Bbrc.1994.1169  0.685
1994 Schwartz JC, Diaz J, Griffon N, Levesque D, Martres MP, Sokoloff P. Multiple dopamine receptors: the D3 receptor and actions of substances of abuse. Exs. 71: 81-92. PMID 8032175  0.353
1994 Diaz J, Lévesque D, Griffon N, Lammers CH, Martres MP, Sokoloff P, Schwartz JC. Opposing roles for dopamine D2 and D3 receptors on neurotensin mRNA expression in nucleus accumbens. The European Journal of Neuroscience. 6: 1384-7. PMID 7981879  0.312
1994 Ligneau X, Garbarg M, Vizuete ML, Diaz J, Purand K, Stark H, Schunack W, Schwartz JC. [125I]iodoproxyfan, a new antagonist to label and visualize cerebral histamine H3 receptors. The Journal of Pharmacology and Experimental Therapeutics. 271: 452-9. PMID 7965746  0.397
1994 Pilon C, Lévesque D, Dimitriadou V, Griffon N, Martres MP, Schwartz JC, Sokoloff P. Functional coupling of the human dopamine D3 receptor in a transfected NG 108-15 neuroblastoma-glioma hybrid cell line. European Journal of Pharmacology. 268: 129-39. PMID 7957635 DOI: 10.1016/0922-4106(94)90182-1  0.492
1993 Rietschel M, Nöthen MM, Lannfelt L, Sokoloff P, Schwartz JC, Lanczik M, Fritze J, Cichon S, Fimmers R, Körner J. A serine to glycine substitution at position 9 in the extracellular N-terminal part of the dopamine D3 receptor protein: no role in the genetic predisposition to bipolar affective disorder. Psychiatry Research. 46: 253-9. PMID 8493294 DOI: 10.1016/0165-1781(93)90093-V  0.357
1993 Wiese C, Lannfelt L, Kristbjarnarson H, Yang L, Zoega T, Sokoloff P, Ivarsson O, Schwartz JC, Moises HW, Helgason T. No evidence of linkage between schizophrenia and D3 dopamine receptor gene locus in Icelandic pedigrees. Psychiatry Research. 46: 69-78. PMID 8464957 DOI: 10.1016/0165-1781(93)90009-6  0.353
1993 Ruat M, Traiffort E, Leurs R, Tardivel-Lacombe J, Diaz J, Arrang JM, Schwartz JC. Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation. Proceedings of the National Academy of Sciences of the United States of America. 90: 8547-51. PMID 8397408 DOI: 10.1073/Pnas.90.18.8547  0.612
1993 Søe-Jensen P, Knigge U, Garbarg M, Kjaer A, Rouleau A, Bach FW, Schwartz JC, Warberg J. Responses of anterior pituitary hormones and hypothalamic histamine to blockade of histamine synthesis and to selective activation or inactivation of presynaptic histamine H3 receptors in stressed rats. Neuroendocrinology. 57: 532-40. PMID 8391665 DOI: 10.1159/000126402  0.407
1993 Ruat M, Traiffort E, Arrang JM, Tardivel-Lacombe J, Diaz J, Leurs R, Schwartz JC. A novel rat serotonin (5-HT6) receptor: molecular cloning, localization and stimulation of cAMP accumulation. Biochemical and Biophysical Research Communications. 193: 268-76. PMID 8389146 DOI: 10.1006/Bbrc.1993.1619  0.656
1993 Pollard H, Moreau J, Arrang JM, Schwartz JC. A detailed autoradiographic mapping of histamine H3 receptors in rat brain areas. Neuroscience. 52: 169-89. PMID 8381924  0.369
1993 Garbarg M, Schwartz JC. The histamine H3 receptor: pharmacology and potential therapeutic applications. Annales Franã§Aises D'Anesthã¨Sie Et De Rã¨Animation. 12: 114-5. PMID 8368582 DOI: 10.1016/S0750-7658(05)81019-6  0.341
1993 Schwartz JC, Levesque D, Martres MP, Sokoloff P. Dopamine D3 receptor: basic and clinical aspects. Clinical Neuropharmacology. 16: 295-314. PMID 8104095 DOI: 10.1097/00002826-199308000-00002  0.458
1993 Yang L, Li T, Wiese C, Lannfelt L, Sokoloff P, Xu CT, Zeng Z, Schwartz JC, Liu X, Moises HW. No association between schizophrenia and homozygosity at the D3 dopamine receptor gene. American Journal of Medical Genetics. 48: 83-6. PMID 8103292 DOI: 10.1002/Ajmg.1320480205  0.38
1993 Giros B, Sokoloff P, Martres MP, Lannfelt L, Andrieux M, Besançon R, Pilon C, Bouthenet ML, Souil E, Schwartz JC. The third dopamine receptor (D3): new perspectives in therapeutics. Psychopharmacology Series. 10: 82-93. PMID 8103228 DOI: 10.1007/978-3-642-78010-3_8  0.597
1993 Martínez-Mir MI, Pollard H, Moreau J, Traiffort E, Ruat M, Schwartz JC, Palacios JM. Loss of striatal histamine H2 receptors in Huntington's chorea but not in Parkinson's disease: comparison with animal models. Synapse (New York, N.Y.). 15: 209-20. PMID 7904088 DOI: 10.1002/Syn.890150306  0.659
1993 Di Marzo V, Vial D, Sokoloff P, Schwartz JC, Piomelli D. Selection of alternative G-mediated signaling pathways at the dopamine D2 receptor by protein kinase C. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 13: 4846-53. PMID 7693893 DOI: 10.1523/Jneurosci.13-11-04846.1993  0.423
1992 Ruat M, Traiffort E, Garbarg M, Schwartz JC, Demonchaux P, Ife RJ, Tertiuk W, Ganellin CR. Design of an affinity matrix for purification of the histamine H1 receptor from guinea pig cerebellum. Journal of Neurochemistry. 58: 350-6. PMID 1727441 DOI: 10.1111/J.1471-4159.1992.Tb09317.X  0.656
1992 Hirschfeld J, Buschauer A, Elz S, Schunack W, Ruat M, Traiffort E, Schwartz JC. Iodoaminopotentidine and related compounds: a new class of ligands with high affinity and selectivity for the histamine H2 receptor. Journal of Medicinal Chemistry. 35: 2231-8. PMID 1613748 DOI: 10.1021/Jm00090A013  0.663
1992 Sokoloff P, Giros B, Martres MP, Andrieux M, Besancon R, Pilon C, Bouthenet ML, Souil E, Schwartz JC. Localization and function of the D3 dopamine receptor. Arzneimittel-Forschung. 42: 224-30. PMID 1586393  0.605
1992 Lévesque D, Diaz J, Pilon C, Martres MP, Giros B, Souil E, Schott D, Morgat JL, Schwartz JC, Sokoloff P. Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin. Proceedings of the National Academy of Sciences of the United States of America. 89: 8155-9. PMID 1518841 DOI: 10.1073/Pnas.89.17.8155  0.629
1992 Ruat M, Traiffort E, Leurs R, Arrang JM, Kouyoumdjian G, Tardivel-Lacombe J, Piomelli D, Diaz G, Schwartz JC. Molecular biology and pharmacology of histamine receptor subtypes. Clinical Neuropharmacology. 15: 149A-150A. PMID 1498787  0.655
1992 Schwartz JC. Multiple dopamine receptors: functional implications. Clinical Neuropharmacology. 15: 1A-2A. PMID 1498771  0.302
1992 Garbarg M, Arrang JM, Rouleau A, Ligneau X, Tuong MD, Schwartz JC, Ganellin CR. S-[2-(4-imidazolyl)ethyl]isothiourea, a highly specific and potent histamine H3 receptor agonist. The Journal of Pharmacology and Experimental Therapeutics. 263: 304-10. PMID 1383495  0.344
1992 Sokoloff P, Martres MP, Giros B, Bouthenet ML, Schwartz JC. Heterogeneity and regulation of central dopamine receptor subtypes studied by cDNA cloning methodology. Neurochemistry International. 20: 27S-32S. PMID 1365440 DOI: 10.1016/0197-0186(92)90207-8  0.626
1992 Martres MP, Sokoloff P, Giros B, Bouthenet ML, Pilon C, Lannfelt L, Schwartz JC. [Dopaminergic receptors, multiple targets for neuroleptics]. Annales Mã©Dico-Psychologiques. 150: 119-23. PMID 1364189  0.56
1992 Sokoloff P, Andrieux M, Besançon R, Pilon C, Martres MP, Giros B, Schwartz JC. Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptor. European Journal of Pharmacology. 225: 331-7. PMID 1354163 DOI: 10.1016/0922-4106(92)90107-7  0.636
1992 Traiffort E, Pollard H, Moreau J, Ruat M, Schwartz JC, Martinez-Mir MI, Palacios JM. Pharmacological characterization and autoradiographic localization of histamine H2 receptors in human brain identified with [125I]iodoaminopotentidine. Journal of Neurochemistry. 59: 290-9. PMID 1351926 DOI: 10.1111/J.1471-4159.1992.Tb08903.X  0.702
1992 Sokoloff P, Martres MP, Giros B, Bouthenet ML, Schwartz JC. The third dopamine receptor (D3) as a novel target for antipsychotics. Biochemical Pharmacology. 43: 659-66. PMID 1347215 DOI: 10.1016/0006-2952(92)90227-A  0.613
1992 Traiffort E, Ruat M, Arrang JM, Leurs R, Piomelli D, Schwartz JC. Expression of a cloned rat histamine H2 receptor mediating inhibition of arachidonate release and activation of cAMP accumulation. Proceedings of the National Academy of Sciences of the United States of America. 89: 2649-53. PMID 1313563 DOI: 10.1073/Pnas.89.7.2649  0.73
1992 Martres MP, Sokoloff P, Giros B, Schwartz JC. Effects of dopaminergic transmission interruption on the D2 receptor isoforms in various cerebral tissues. Journal of Neurochemistry. 58: 673-9. PMID 1309568 DOI: 10.1111/J.1471-4159.1992.Tb09770.X  0.586
1992 Schwartz JC, Giros B, Martres MP, Sokoloff P. The dopamine receptor family: molecular biology and pharmacology Seminars in Neuroscience. 4: 99-108. DOI: 10.1016/1044-5765(92)90008-P  0.632
1991 Giros B, Martres MP, Pilon C, Sokoloff P, Schwartz JC. Shorter variants of the D3 dopamine receptor produced through various patterns of alternative splicing. Biochemical and Biophysical Research Communications. 176: 1584-92. PMID 2039532 DOI: 10.1016/0006-291X(91)90469-N  0.625
1991 Ruat M, Traiffort E, Arrang JM, Leurs R, Schwartz JC. Cloning and tissue expression of a rat histamine H2-receptor gene. Biochemical and Biophysical Research Communications. 179: 1470-8. PMID 1930188 DOI: 10.1016/0006-291X(91)91738-X  0.698
1991 Le Coniat M, Sokoloff P, Hillion J, Martres MP, Giros B, Pilon C, Schwartz JC, Berger R. Chromosomal localization of the human D3 dopamine receptor gene. Human Genetics. 87: 618-20. PMID 1916765 DOI: 10.1007/Bf00209024  0.586
1991 Piomelli D, Pilon C, Giros B, Sokoloff P, Martres MP, Schwartz JC. Dopamine activation of the arachidonic acid cascade as a basis for D1/D2 receptor synergism. Nature. 353: 164-7. PMID 1909771 DOI: 10.1038/353164a0  0.59
1991 Traiffort E, Ruat M, Schwartz JC. Interaction of mianserin, amitriptyline and haloperidol with guinea pig cerebral histamine H2 receptors studied with [125I]iodoaminopotentidine. European Journal of Pharmacology. 207: 143-8. PMID 1879459 DOI: 10.1016/0922-4106(91)90089-Z  0.708
1991 Bouthenet ML, Souil E, Martres MP, Sokoloff P, Giros B, Schwartz JC. Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA. Brain Research. 564: 203-19. PMID 1839781 DOI: 10.1016/0006-8993(91)91456-B  0.588
1991 Lipp R, Arrang JM, Buschmann J, Garbarg M, Luger P, Schunack W, Schwartz JC. Novel chiral H3-receptor agonists. Agents and Actions. Supplements. 33: 277-82. PMID 1711275 DOI: 10.1007/978-3-0348-7309-3_18  0.377
1991 Ruat M, Traiffort E, Bouthenet ML, Souil E, Pollard H, Moreau J, Schwartz JC, Martinez-Mir I, Palacios JM, Hirschfeld J. Reversible and irreversible labelling of H1- and H2 -receptors using novel [125I] probes. Agents and Actions. Supplements. 33: 123-44. PMID 1675831  0.698
1991 Llorens-Cortes C, Zini S, Gros C, Schwartz JC. Dopaminergic regulation of enkephalin release. Journal of Neurochemistry. 56: 1368-75. PMID 1672147 DOI: 10.1111/j.1471-4159.1991.tb11434.x  0.376
1991 Ganellin CR, Jayes D, Khalaf YS, Tertiuk W, Arrang J, Defontaine N, Schwartz J. Synthesis of pyridyl isosteres of thioperamide as H3-receptor histamine antagonists Collection of Czechoslovak Chemical Communications. 56: 2448-2455. DOI: 10.1135/Cccc19912448  0.456
1990 Schwartz JC, Arrang JM, Garbarg M, Pollard H. Histamine H3 receptors in the brain: potent and selective ligands. Psychopharmacology Series. 7: 10-9. PMID 2687850 DOI: 10.1007/978-3-642-74430-3_2  0.346
1990 Ruat M, Traiffort E, Bouthenet ML, Schwartz JC, Hirschfeld J, Buschauer A, Schunack W. Reversible and irreversible labeling and autoradiographic localization of the cerebral histamine H2 receptor using [125I]iodinated probes. Proceedings of the National Academy of Sciences of the United States of America. 87: 1658-62. PMID 2308927 DOI: 10.1073/Pnas.87.5.1658  0.705
1990 Llorens-Cortes C, Giros B, Schwartz JC. A novel potential metallopeptidase derived from the enkephalinase gene by alternative splicing. Journal of Neurochemistry. 55: 2146-8. PMID 2230815 DOI: 10.1111/J.1471-4159.1990.Tb05810.X  0.524
1990 Llorens-Cortes C, Van Amsterdam JG, Giros B, Quach TT, Schwartz JC. Enkephalin biosynthesis and release in mouse striatum are inhibited by GABA receptor stimulation: compared changes in preproenkephalin mRNA and Tyr-Gly-Gly levels. Brain Research. Molecular Brain Research. 8: 227-33. PMID 2170800 DOI: 10.1016/0169-328X(90)90021-5  0.59
1990 Lin JS, Sakai K, Vanni-Mercier G, Arrang JM, Garbarg M, Schwartz JC, Jouvet M. Involvement of histaminergic neurons in arousal mechanisms demonstrated with H3-receptor ligands in the cat. Brain Research. 523: 325-30. PMID 2169324 DOI: 10.1016/0006-8993(90)91508-E  0.424
1990 Lecomte J, Baumer P, Lim C, Duchier J, Cournot A, Dussaule J, Ardaillou R, Gros C, Chaignon B, Souque A, Schwartz J. Stereoselective protection of exogenous and endogenous atrial natriuretic factor by enkephalinase inhibitors in mice and humans. European Journal of Pharmacology. 179: 65-73. PMID 2163851 DOI: 10.1016/0014-2999(90)90402-R  0.315
1990 Llorens-Cortes C, Giros B, Quach TT, Schwartz JC. Adaptative changes in two indices of enkephalin neuron activity in mouse striatum following GABAergic stimulation. Progress in Clinical and Biological Research. 328: 203-6. PMID 2154779  0.464
1990 Giros B, Martres MP, Sokoloff P, Schwartz JC. [Gene cloning of human dopaminergic D3 receptor and identification of its chromosome]. Comptes Rendus De L'Acadã©Mie Des Sciences. Sã©Rie Iii, Sciences De La Vie. 311: 501-8. PMID 2129115  0.545
1990 Michael-Titus A, Dourmap N, Costentin J, Schwartz JC. Role of delta opioid receptors in the effects of inhibitors of enkephalin-degrading peptidases on the horizontal and vertical components of locomotion in mice. Neuropeptides. 15: 89-100. PMID 1981928 DOI: 10.1016/0143-4179(90)90044-Y  0.479
1990 Martinez-Mir MI, Pollard H, Moreau J, Arrang JM, Ruat M, Traiffort E, Schwartz JC, Palacios JM. Three histamine receptors (H1, H2 and H3) visualized in the brain of human and non-human primates. Brain Research. 526: 322-7. PMID 1979518 DOI: 10.1016/0006-8993(90)91240-H  0.684
1990 Rognan D, Sokoloff P, Mann A, Martres MP, Schwartz JC, Costentin J, Wermuth CG. Optically active benzamides as predictive tools for mapping the dopamine D2 receptor. European Journal of Pharmacology. 189: 59-70. PMID 1977603 DOI: 10.1016/0922-4106(90)90230-U  0.57
1990 Sokoloff P, Giros B, Martres MP, Bouthenet ML, Schwartz JC. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature. 347: 146-51. PMID 1975644 DOI: 10.1038/347146A0  0.597
1990 Arrang JM, Roy J, Morgat JL, Schunack W, Schwartz JC. Histamine H3 receptor binding sites in rat brain membranes: modulations by guanine nucleotides and divalent cations. European Journal of Pharmacology. 188: 219-27. PMID 1694777 DOI: 10.1016/0922-4106(90)90005-I  0.472
1990 Gulat-Marnay C, Lafitte A, Arrang JM, Schwartz JC. Modulation of histamine release in the rat brain by kappa-opioid receptors. Journal of Neurochemistry. 55: 47-53. PMID 1693948 DOI: 10.1111/J.1471-4159.1990.Tb08819.X  0.445
1989 Vargas F, Tuong MD, Schwartz JC. Inhibitors and dipeptide substrates for a microsomal tyrosylsulfotransferase from rat brain. Journal of Enzyme Inhibition. 1: 105-12. PMID 3508909 DOI: 10.3109/14756368609020109  0.319
1989 Arrang JM, Defontaine N, Schwartz JC. Phencyclidine blocks histamine H3-receptors in rat brain. European Journal of Pharmacology. 157: 31-5. PMID 2853072 DOI: 10.1016/0014-2999(88)90467-0  0.495
1989 Arrang JM, Garbarg M, Lancelot JC, Lecomte JM, Pollard H, Robba M, Schunack W, Schwartz JC. Highly potent and selective ligands for a new class H3 of histamine receptor. Investigative Radiology. S130-2. PMID 2848779 DOI: 10.1097/00004424-198809001-00017  0.365
1989 Ruat M, Schwartz JC. Photoaffinity labeling and electrophoretic identification of the H1-receptor: comparison of several brain regions and animal species. Journal of Neurochemistry. 53: 335-9. PMID 2746224 DOI: 10.1111/J.1471-4159.1989.Tb07339.X  0.425
1989 Llorens-Cortes C, Martres MP, Van Amsterdam Y, Giros B, Gros C, Pollard H, Schwartz JC. [Dopamine and enkephalins. Effects of dopaminergic agents on the levels of striatal tyrosyl-glycyl-glycine]. L'Encã©Phale. 15: 105-9. PMID 2743934  0.485
1989 Garbarg M, Tuong MD, Gros C, Schwartz JC. Effects of histamine H3-receptor ligands on various biochemical indices of histaminergic neuron activity in rat brain. European Journal of Pharmacology. 164: 1-11. PMID 2568933 DOI: 10.1016/0014-2999(89)90225-2  0.34
1989 Malfroy B, Kado-Fong H, Gros C, Giros B, Schwartz JC, Hellmiss R. Molecular cloning and amino acid sequence of rat kidney aminopeptidase M: a member of a super family of zinc-metallohydrolases. Biochemical and Biophysical Research Communications. 161: 236-41. PMID 2567164 DOI: 10.1016/0006-291X(89)91586-6  0.521
1989 Gulat-Marnay C, Lafitte A, Arrang J, Schwartz J. Modulation of Histamine Release and Synthesis in the Brain Mediated by α2‐Adrenoceptors Journal of Neurochemistry. 53: 519-524. PMID 2545819 DOI: 10.1111/J.1471-4159.1989.Tb07364.X  0.42
1989 Giros B, Sokoloff P, Martres MP, Riou JF, Emorine LJ, Schwartz JC. Alternative splicing directs the expression of two D2 dopamine receptor isoforms. Nature. 342: 923-6. PMID 2531847 DOI: 10.1038/342923A0  0.641
1989 Sokoloff P, Riou JF, Martres MP, Schwartz JC. Presence of dopamine D-2 receptors in human tumoral cell lines. Biochemical and Biophysical Research Communications. 162: 575-82. PMID 2527031 DOI: 10.1016/0006-291X(89)92349-8  0.375
1989 Gulat-Marnay C, Lafitte A, Arrang JM, Schwartz JC. Regulation of histamine release and synthesis in the brain by muscarinic receptors. Journal of Neurochemistry. 52: 248-54. PMID 2462019 DOI: 10.1111/J.1471-4159.1989.Tb10924.X  0.467
1988 Ruat M, Körner M, Garbarg M, Gros C, Schwartz JC, Tertiuk W, Ganellin CR. Characterization of histamine H1-receptor binding peptides in guinea pig brain using [125I]iodoazidophenpyramine, an irreversible specific photoaffinity probe. Proceedings of the National Academy of Sciences of the United States of America. 85: 2743-7. PMID 3357888  0.372
1988 Gros C, Giros B, Schwartz JC, Vlaiculescu A, Costentin J, Lecomte JM. Potent inhibition of cerebral aminopeptidases by carbaphethiol, a parenterally active compound. Neuropeptides. 12: 111-8. PMID 3241626 DOI: 10.1016/0143-4179(88)90040-6  0.506
1988 Bouthenet ML, Ruat M, Sales N, Garbarg M, Schwartz JC. A detailed mapping of histamine H1-receptors in guinea-pig central nervous system established by autoradiography with [125I]iodobolpyramine. Neuroscience. 26: 553-600. PMID 3173689 DOI: 10.1016/0306-4522(88)90167-4  0.329
1988 De la Baume S, Schwartz JC. Labelling and exploration of the active site of enkephalinase (EC 3.4.24.11) in kidney membranes with [3H]thiorphan as ligand. European Journal of Pharmacology. 149: 121-9. PMID 3165067 DOI: 10.1016/0014-2999(88)90049-0  0.361
1988 Arrang JM, Devaux B, Chodkiewicz JP, Schwartz JC. H3-receptors control histamine release in human brain. Journal of Neurochemistry. 51: 105-8. PMID 2454293 DOI: 10.1111/J.1471-4159.1988.Tb04841.X  0.428
1988 Arrang JM, Garbarg M, Schwartz JC. Autoinhibition of histamine synthesis mediated by presynaptic H3-receptors. Neuroscience. 23: 149-57. PMID 2446202 DOI: 10.1016/0306-4522(87)90279-X  0.377
1988 ARRANG JM, GARBARG M, LANCELOT JC, LECOMTE JM, POLLARD H, ROBBA M, SCHUNACK W, SCHWARTZ JC. Highly Potent and Selective Ligands for a New Class H3 of Histamine Receptor Investigative Radiology. 23: S133. DOI: 10.1097/00004424-198809000-00019  0.31
1987 Pollard H, De la Baume S, Bouthenet ML, Schwartz JC, Ronco P, Verroust P. Characterisation of two probes for the localisation of enkephalinase in rat brain: [3H]thiorphan and a 125I-labeled monoclonal antibody. European Journal of Pharmacology. 133: 155-64. PMID 3545855 DOI: 10.1016/0014-2999(87)90146-4  0.335
1987 Brion F, Schwartz JC, Vargas F. Properties and localization of the sulfate-activating system in rat brain. Journal of Neurochemistry. 48: 1171-7. PMID 3493327 DOI: 10.1111/J.1471-4159.1987.Tb05643.X  0.307
1987 Marçais-Collado H, Uchida G, Costentin J, Schwartz JC, Lecomte JM. Naloxone-reversible antidiarrheal effects of enkephalinase inhibitors. European Journal of Pharmacology. 144: 125-32. PMID 3481337 DOI: 10.1016/0014-2999(87)90510-3  0.51
1987 Giros B, Gros C, Schwartz JC, Danvy D, Plaquevent JC, Duhamel L, Duhamel P, Vlaiculescu A, Costentin J, Lecomte JM. Enantiomers of thiorphan and acetorphan: correlation between enkephalinase inhibition, protection of endogenous enkephalins and behavioral effects. The Journal of Pharmacology and Experimental Therapeutics. 243: 666-73. PMID 3479550  0.506
1987 Garbarg M, Schwartz JC. Histamine receptors in the brain. New England and Regional Allergy Proceedings. 6: 195-200. PMID 3041196 DOI: 10.2500/108854185779045233  0.502
1987 Giros B, Gros C, Llorens-Cortes C, Schwartz JC. [Opioid peptides: metabolism and receptors]. Gastroentã©Rologie Clinique Et Biologique. 11: 7B-13B. PMID 3038654  0.509
1987 Giros B, Schwartz JC. [Opioid peptides and their receptors]. La Revue Du Praticien. 37: 1695-8, 1701-2. PMID 3035700  0.514
1987 Schwartz JC, Giros B, Gros C, Llorens-Cortes C, Arrang JM, Garbarg M, Pollard H. Novel agents affecting enkephalinergic and histaminergic transmissions in brain. Cephalalgia : An International Journal of Headache. 7: 32-5. PMID 2894899 DOI: 10.1177/03331024870070S610  0.453
1987 Pollard H, Llorens-Cortes C, Couraud J, Ronco P, Verroust P, Schwartz J. Enkephalinase (EC 3.4.24.11) is highly localized to a striatonigral pathway in rat brain. Neuroscience Letters. 77: 267-271. PMID 2441326 DOI: 10.1016/0304-3940(87)90510-6  0.311
1987 Blakemore RC, Ganellin CR, Garbarg M, Gros C, Ife RJ, Körner M, Ruat M, Schwartz JC, Tertiuk W, Theobald CJ. Iodobolpyramine and other iodinated derivatives as ligands for detecting histamine H1 receptors European Journal of Medicinal Chemistry. 22: 91-100. DOI: 10.1016/0223-5234(87)90002-X  0.467
1986 Korner M, Bouthenet ML, Ganellin CR, Garbarg M, Gros C, Ife RJ, Sales N, Schwartz JC. [125I]Iodobolpyramine, a highly sensitive probe for histamine H1-receptors in guinea-pig brain. European Journal of Pharmacology. 120: 151-60. PMID 3948916 DOI: 10.1016/0014-2999(86)90535-2  0.495
1986 Llorens-Cortes C, Gros C, Schwartz JC. Study of endogenous Tyr-Gly-Gly, a putative enkephalin metabolite, in mouse brain: validation of a radioimmunoassay, localisation and effects of peptidase inhibitors. European Journal of Pharmacology. 119: 183-91. PMID 3912194 DOI: 10.1016/0014-2999(85)90294-8  0.331
1986 Schwartz JC, de la Baume S, Bouthenet ML, Giros B, Gros C, Llorens-Cortes C, Pollard H, Sales N, Solhonne B, Costentin J. [Neuropeptidases responsible for the inactivation of enkephalins and the pharmacology of their inhibitors]. Journal De Pharmacologie. 17: 104-22. PMID 3546953  0.451
1986 Giros B, Llorens-Cortes C, Gros C, Schwartz JC. The endogenous tripeptide Tyr-Gly-Gly as a possible metabolite of opioid peptides in rat brain: identification, regional distribution, effects of lesions and formation in depolarized slices. Peptides. 7: 669-77. PMID 3532054 DOI: 10.1016/0196-9781(86)90043-4  0.566
1986 Llorens-Cortes C, Gros C, Schwartz JC. Steady-state level and turnover rate of the tripeptide Tyr-Gly-Gly as indexes of striatal enkephalin release in vivo and their reduction during pentobarbital anesthesia. Proceedings of the National Academy of Sciences of the United States of America. 83: 6226-30. PMID 3526354 DOI: 10.1073/Pnas.83.16.6226  0.308
1986 Costentin J, Vlaiculescu A, Chaillet P, Ben Natan L, Aveaux D, Schwartz JC. Dissociated effects of inhibitors of enkephalin-metabolising peptidases or naloxone on various nociceptive responses. European Journal of Pharmacology. 123: 37-44. PMID 3519246 DOI: 10.1016/0014-2999(86)90684-9  0.524
1986 Giros B, Llorens-Cortes C, Gros C, Schwartz JC. The endogenous tripeptide Tyr-Gly-Gly as an extracellular metabolite of enkephalins in rat brain: origin and metabolism. Nida Research Monograph. 75: 271-4. PMID 3123944  0.51
1986 Martres MP, Sales N, Bouthenet ML, Schwartz JC. Localisation and pharmacological characterisation of D-2 dopamine receptors in rat cerebral neocortex and cerebellum using [125I]iodosulpride. European Journal of Pharmacology. 118: 211-9. PMID 2935411 DOI: 10.1016/0014-2999(85)90131-1  0.395
1986 Gros C, Solhonne B, Giros B, Pollard H, Salès N, Schwartz JC, Ronco P, Verroust P. Immunohistochemical and subcellular studies of aminopeptidase M localization in rat brain: microvessels and synaptic membranes. Nida Research Monograph. 75: 303-6. PMID 2893270  0.457
1986 Giros B, Gros C, Solhonne B, Schwartz JC. Characterization of aminopeptidases responsible for inactivating endogenous (Met5)enkephalin in brain slices using peptidase inhibitors and anti-aminopeptidase M antibodies. Molecular Pharmacology. 29: 281-7. PMID 2869404  0.488
1986 Arrang JM, Schwartz JC, Schunack W. Stereoselectivity of the histamine H3-presynaptic autoreceptor. European Journal of Pharmacology. 117: 109-14. PMID 2417862 DOI: 10.1016/0014-2999(85)90478-9  0.444
1986 Schwartz J, Costentin J, Lecomte J. Schwartz et al. reply Trends in Pharmacological Sciences. 7: 89-90. DOI: 10.1016/0165-6147(86)90268-3  0.436
1986 Schwartz J, Arrang J, Garbarg M. Three classes of histamine receptors in brain Trends in Pharmacological Sciences. 7: 24-28. DOI: 10.1016/0165-6147(86)90236-1  0.507
1985 Vasse M, Protais P, Costentin J, Schwartz JC. Unexpected potentiation by discriminant benzamide derivatives of stereotyped behaviours elicited by dopamine agonists in mice. Naunyn-Schmiedeberg's Archives of Pharmacology. 329: 108-16. PMID 4040215 DOI: 10.1007/Bf00501198  0.448
1985 Sokoloff P, Redouane K, Brann M, Martres MP, Schwartz JC. 3H-(-)DO 710 discriminates guanine nucleotide sensitive and insensitive dopamine binding sites Naunyn-Schmiedeberg's Archives of Pharmacology. 329: 236-243. PMID 4022135 DOI: 10.1007/Bf00501874  0.42
1985 Sokoloff P, Brann M, Redouane K, Martres MP, Schwartz JC, Bouthenet ML, Sales N, Mann A, Hamdi P, Wermuth CG, Roy J, Morgat JL. The use of [3H](-)-DO 710 as selective dopaminergic ligand for binding and autoradiographic studies European Journal of Pharmacology. 107: 243-251. PMID 3979426 DOI: 10.1016/0014-2999(85)90064-0  0.468
1985 Vargas F, Frerot O, Tuong MD, Zuzel K, Rose C, Schwartz JC. Sulfation and desulfation of cerebral cholecystokinin. Annals of the New York Academy of Sciences. 448: 110-20. PMID 3861116 DOI: 10.1111/J.1749-6632.1985.Tb29911.X  0.305
1985 Martres MP, Bouthenet ML, Sales N, Sokoloff P, Schwartz JC. Widespread distribution of brain dopamine receptors evidenced with [125I]iodosulpride, a highly selective ligand. Science (New York, N.Y.). 228: 752-5. PMID 3838821 DOI: 10.1126/Science.3838821  0.465
1985 Redouane K, Sokoloff P, Schwartz JC, Hamdi P, Mann A, Wermuth CG, Roy J, Morgat JL. Photoaffinity labeling of D-2 dopamine binding subunits from rat striatum, anterior pituitary and olfactory bulb with a new probe, [3H]azidosulpride. Biochemical and Biophysical Research Communications. 130: 1086-92. PMID 3161508 DOI: 10.1016/0006-291X(85)91727-9  0.457
1985 Bouthenet M, Sales N, Schwartz J. Autoradiographic localisation of3H-apomorphine binding sites in rat brain Naunyn-Schmiedebergs Archives of Pharmacology. 330: 1-8. PMID 2995839 DOI: 10.1007/Bf00586702  0.375
1985 Arrang JM, Garbarg M, Quach TT, Dam Trung TuongM, Yeramian E, Schwartz JC. Actions of betahistine at histamine receptors in the brain. European Journal of Pharmacology. 111: 73-84. PMID 2990946 DOI: 10.1016/0014-2999(85)90115-3  0.502
1985 Gros C, Giros B, Schwartz JC. Purification of membrane-bound aminopeptidase from rat brain: identification of aminopeptidase M. Neuropeptides. 5: 485-8. PMID 2860607 DOI: 10.1016/0143-4179(85)90060-5  0.53
1985 Gros C, Giros B, Llorens C, Malfroy B, Pollard H, Pachot I, Schwartz JC, Mazie JC. Enkephalin metabolism and its inhibition. Biochemical Society Transactions. 13: 47-50. PMID 2860040 DOI: 10.1042/Bst0130047  0.495
1985 Gros C, Giros B, Schwartz JC. Identification of aminopeptidase M as an enkephalin-inactivating enzyme in rat cerebral membranes. Biochemistry. 24: 2179-85. PMID 2859885 DOI: 10.1021/Bi00330A011  0.5
1985 Schwartz J, Costentin J, Lecomte J. Pharmacology of enkephalinase inhibitors Trends in Pharmacological Sciences. 6: 472-476. DOI: 10.1016/0165-6147(85)90226-3  0.505
1984 Llorens-Cortes C, Schwartz JC. Changes in turnover of cerebral monoamines following inhibition of enkephalin metabolism by thiorphan and bestatin. European Journal of Pharmacology. 104: 369-74. PMID 6594244 DOI: 10.1016/0014-2999(84)90415-1  0.359
1984 Sokoloff P, Martres M, Delandre M, Redouane K, Schwartz J. 3H-domperidone binding sites differ in rat striatum and pituitary Naunyn-Schmiedebergs Archives of Pharmacology. 327: 221-227. PMID 6493362 DOI: 10.1007/Bf00502453  0.354
1984 Protais P, Bonnet JJ, Costentin J, Schwartz JC. Rat climbing behavior elicited by stimulation of cerebral dopamine receptors. Naunyn-Schmiedeberg's Archives of Pharmacology. 325: 93-101. PMID 6425703 DOI: 10.1007/Bf00506188  0.49
1984 Martres MP, Sokoloff P, Delandre M, Schwartz JC, Protais P, Costentin J. Selection of dopamine antagonists discriminating various behavioral responses and radioligand binding sites. Naunyn-Schmiedeberg's Archives of Pharmacology. 325: 102-15. PMID 6144046 DOI: 10.1007/Bf00506189  0.534
1983 Chaillet P, Marçais-Collado H, Costentin J, Yi CC, De La Baume S, Schwartz JC. Inhibition of enkephalin metabolism by, and antinociceptive activity of, bestatin, an aminopeptidase inhibitor. European Journal of Pharmacology. 86: 329-36. PMID 6572590 DOI: 10.1016/0014-2999(83)90181-4  0.56
1983 de la Baume S, Yi CC, Schwartz JC, Chaillet P, Marcais-Collado H, Costentin J. Participation of both 'enkephalinase' and aminopeptidase activities in the metabolism of endogenous enkephalins. Neuroscience. 8: 143-51. PMID 6300726 DOI: 10.1016/0306-4522(83)90033-7  0.399
1982 de la Baume S, Gros C, Yi CC, Chaillet P, Marcais-Collado H, Costentin J, Schwartz JC. Selective participation of both "enkephalinase" and aminopeptidase activities in the metabolism of endogenous enkephalins. Life Sciences. 31: 1753-6. PMID 6759827 DOI: 10.1016/0024-3205(82)90202-8  0.479
1982 Schwartz JC, De La Baume S, Yi CC, Chaillet P, Marcais-Collado H, Costentin J. Enkephalin metabolism in brain and its inhibition. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 6: 665-71. PMID 6298893 DOI: 10.1016/S0278-5846(82)80166-8  0.524
1982 Quach TT, Rose C, Duchemin AM, Schwartz JC. Glycogenolysis induced by serotonin in brain: identification of a new class of receptor. Nature. 298: 373-5. PMID 6123954 DOI: 10.1038/298373a0  0.346
1981 Llorens C, Schwartz JC. Enkephalinase activity in rat peripheral organs. European Journal of Pharmacology. 69: 113-6. PMID 7009170 DOI: 10.1016/0014-2999(81)90609-9  0.34
1981 Schwartz J, Garbarg M, Quach TT. Histamine receptors in brain as targets for tricyclic antidepressants Trends in Pharmacological Sciences. 2: 122-125. DOI: 10.1016/0165-6147(81)90285-6  0.472
1980 Sokoloff P, Martres M, Schwartz J. 3H-apomorphine labels both dopamine postsynaptic receptors and autoreceptors. Nature. 288: 283-286. PMID 7432527 DOI: 10.1038/288283A0  0.496
1980 Patey G, de la Baume S, Gros C, Schwartz JC. Ontogenesis of enkephalinergic systems in rat brain: post-natal changes in enkephalin levels, receptors and degrading enzyme activities. Life Sciences. 27: 245-52. PMID 6250001 DOI: 10.1016/0024-3205(80)90144-7  0.427
1980 Dam Trung Tuong M, Garbarg M, Schwartz JC. Pharmacological specificity of brain histamine H2-receptors differs in intact cells and cell-free preparations. Nature. 287: 548-51. PMID 6106900 DOI: 10.1038/287548A0  0.322
1980 Guyon A, Roques BP, Guyon F, Foucault A, Perdrisot R, Swerts JP, Schwartz JC. Enkephalin degradation in mouse brain studied by a new H.P.L.C. method: further evidence for the involvement of carboxydipeptidase. Life Sciences. 25: 1605-11. PMID 522617 DOI: 10.1016/0024-3205(79)90444-2  0.329
1980 Schwartz JC. Minireview: histamine receptors in brain. Life Sciences. 25: 895-911. PMID 41990 DOI: 10.1016/0024-3205(79)90495-8  0.507
1979 Martres MP, Baudry M, Schwartz JC. Characterization of 3H-domperidone binding on striatal dopamine receptors. Life Sciences. 23: 1781-4. PMID 723450 DOI: 10.1016/0024-3205(78)90108-X  0.455
1979 de la Baume S, Patey G, Marçais H, Protais P, Costentin J, Schwartz JC. Changes in dopamine receptors in mouse striatum following morphine treatments. Life Sciences. 24: 2333-42. PMID 573360 DOI: 10.1016/0024-3205(79)90531-9  0.589
1979 Gacel G, Fournié-Zaluski MC, Fellion E, Roques BP, Senault B, Lecomte JM, Malfroy B, Swerts JP, Schwartz JC. Conformation and biological activities of hexapeptides related to enkephalins: respective roles of the ammonium and hydroxyl groups of tyrosine. Life Sciences. 24: 725-31. PMID 440018 DOI: 10.1016/0024-3205(79)90354-0  0.325
1979 Duchemin AM, Quach TT, Rose C, Schwartz JC. Pharmacological characterization of 3H-LSD binding sites in mouse brain in vivo. Life Sciences. 24: 401-9. PMID 431327 DOI: 10.1016/0024-3205(79)90210-8  0.408
1979 Schwartz J. Opiate receptors on catecholaminergic neurones in brain Trends in Neurosciences. 2: 137-139. DOI: 10.1016/0166-2236(79)90055-9  0.431
1978 Pollard H, Llorens C, Bonnet JJ, Costentin J, Schwartz JC. Opiate receptors on mesolimbic dopaminergic neurons. Neuroscience Letters. 7: 295-9. PMID 19605129 DOI: 10.1016/0304-3940(78)90216-1  0.559
1978 Palacios JM, Schwartz JC, Garbarg M. High affinity binding of 3H-histamine in rat brain. European Journal of Pharmacology. 50: 443-4. PMID 699966 DOI: 10.1016/0014-2999(78)90151-6  0.364
1978 Schwartz JC, Baudry M, Martres MP, Costentin J, Protais P. Increased in vivo binding of 3H-pimozide in mouse striatum following repeated administration of haloperidol. Life Sciences. 23: 1785-9. PMID 569235 DOI: 10.1016/0024-3205(78)90109-1  0.564
1978 Marcais H, Protais P, Costentin J, Schwartz JC. A gradual score to evaluate the climbing behaviour elicited by apomorphine in mice. Psychopharmacology. 56: 233-4. PMID 417378 DOI: 10.1007/Bf00431856  0.442
1978 Schwartz JC, Costentin J, Martres MP, Protais P, Baudry M. Modulation of receptor mechanisms in the CNS: hyper- and hyposensitivity to catecholamines. Neuropharmacology. 17: 665-85. PMID 211458 DOI: 10.1016/0028-3908(78)90080-1  0.54
1978 Quach TT, Rose C, Schwartz JC. [3H]Glycogen hydrolysis in brain slices: responses to neurotransmitters and modulation of noradrenaline receptors. Journal of Neurochemistry. 30: 1335-41. PMID 27582 DOI: 10.1111/j.1471-4159.1978.tb10464.x  0.347
1977 Baudry M, Costentin J, Marcais H, Martres MP, Protais P, Schwartz JC. Decreased responsiveness to low doses of apomorphine after dopamine agonists and the possible involvement of hyposensitivity of dopamine 'autoreceptors'. Neuroscience Letters. 4: 203-7. PMID 19604945 DOI: 10.1016/0304-3940(77)90139-2  0.525
1977 Martres MP, Costentin J, Baudry M, Marcais H, Protais P, Schwartz JC. Long-term changes in the sensitivity of pre-and postsynaptic dopamine receptors in mouse striatum evidenced by behavioural and biochemical studies. Brain Research. 136: 319-37. PMID 922486 DOI: 10.1016/0006-8993(77)90806-X  0.554
1977 Baudry M, Martres MP, Schwartz JC. In vivo binding of 3H-pimozide in mouse striatum: effects of dopamine agonists and antagonists. Life Sciences. 21: 1163-70. PMID 916813 DOI: 10.1016/0024-3205(77)90116-3  0.467
1977 Verdière M, Rose C, Schwartz J. Turnover of cerebral histamine in a stressful situation Brain Research. 129: 107-119. PMID 871922 DOI: 10.1016/0006-8993(77)90973-8  0.341
1977 Costentin J, Marçais H, Protais P, Baudry M, De La Baume S, Martres MP, Schwartz JC. Rapid development of hypersensitivity of striatal dopamine receptors induced by alpha-methylparatyrosine and its prevention by protein synthesis inhibitors. Life Sciences. 21: 307-13. PMID 561281 DOI: 10.1016/0024-3205(77)90510-0  0.585
1977 Verdiere M, Rose C, Schwartz JC. Synthesis and release of histamine studied on slices from rat hypothalamus. European Journal of Pharmacology. 34: 157-68. PMID 63382 DOI: 10.1016/0014-2999(75)90236-8  0.362
1976 Schwartz JC. Histamine as a transmitter in brain. Life Sciences. 17: 503-17. PMID 241888 DOI: 10.1016/0024-3205(75)90083-1  0.346
1976 Audigier Y, Virion A, Schwartz J. Stimulation of cerebral histamine H2 receptors by clonidine. Nature. 262: 307-308. PMID 183124 DOI: 10.1038/262307A0  0.447
1975 Baudry M, Martres MP, Schwartz JC. H1 and H2 receptors in the histamine-induced accumulation of cyclic AMP in guinea pig brain slices. Nature. 253: 362-4. PMID 234179 DOI: 10.1038/253362A0  0.441
1973 Pollard H, Bischoff S, Schwartz JC. Increased synthesis and release of 3H-histamine in rat brain by reserpine European Journal of Pharmacology. 24: 399-401. PMID 4128953 DOI: 10.1016/0014-2999(73)90168-4  0.375
1972 Schwartz JC, Pollard H, Bischoff S, Rehault MC, Verdiere-Sahuque M. Catabolism of 3 H-histamine in the rat brain after intracisternal administration. European Journal of Pharmacology. 16: 326-35. PMID 5132560 DOI: 10.1016/0014-2999(71)90035-5  0.392
1969 Schwartz JC, Ronnberg AL, Cohen Y, Valette G. Histamine formation in rat stomach: study of regulation mechanisms. European Journal of Pharmacology. 5: 272-8. PMID 5772676 DOI: 10.1016/0014-2999(69)90148-4  0.315
Show low-probability matches.